Stock screenerAll disclosures →
EDGAR →
CADL
Conviction 80HealthcareScan · Mon, Aug 10, 2026CADL$10.50-0.90%
ResistanceSupportVol 14Vol MA14 1.03M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price10.50
Change-0.90%
Gap-0.80%
Rel volume0.59×
Avg volume1.14M
Avg $ vol11.38M
SMA 2010.00
SMA 509.46
SMA 2006.68
Price vs 50+10.97%
Price vs 200+57.05%
MA stackbullish
50/200 cross—
Supertrendup · 9.06
RSI (14)60
MACD hist0.04
MACD crossbull · 4d
Stoch %K / %D81 / 84
ADX (14)20
+DI / −DI22 / 17
RSI divergence—
MACD divergence—
ATR %+5.05%
ADR %5.48%
52w high10.59
52w low4.42
From 52w high-0.90%
Above 52w low+137.44%
New 52w highNo
SqueezeOn · 16d
Bollinger width14.93%
%B0.83
Donchian pos80.65%
Donchian high10.82
Donchian low9.16
AVWAP (52w high)9.99
vs AVWAP high+5.05%
AVWAP (52w low)7.26
vs AVWAP low+44.60%
OBV trendFlat
Chaikin MF (20)-0.01
Today vs 20d0.59×
Avg vol (14d)1.03M
Avg vol (20d)1.14M
Avg $ vol (20d)11.38M
Market cap768.97M
RS 3m (vs SPY)+30.25%
RS 6m (vs SPY)+86.07%
RS line new highNo
Trend template8/8
Technical rank88.8
1 week+4.22%
1 month+10.59%
3 months+25.69%
6 months+80.02%
1 year+79.71%
YTD+92.92%
P/E-20.14
P/B5.57
P/S—
P/FCF-19.77
EPS-0.7200
Div yield—
ROE-27.66%
ROA-18.91%
Debt/Eq0.01
Current28.05
EV/EBITDA-12.13
Gross margin—
Net margin—
Rev growth0.00%
EPS growth30.80%
Price target20.17
Target upside92.19%
Analyst ratingBuy
Institutional69.22%
Ent. value575.87M
Revenue31K
Net income-8.86M
Gross profit—
Free cash flow-38.9M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out73.27M
Employees55
ListedTue, Jul 27, 2021
Free float42.26M
Float %77.0%
Short interest12.96M
Days to cover9.0d
Short volume60.6%
Squeeze score79 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.14 vs −$0.22
Last surprise+36.4% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank88.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.09
Support8.55
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CADL
No recent disclosed trades by Congress in CADL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CADL · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sims Mark E. Chief Commercial Officer · Stock Option (Right to Buy) · 2026-07-06 | Grant | 285K | — | 2026-07-06 | 2026-07-08 |
Benz Edward J. JR Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Loggia Nicoletta Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Martell Christopher Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Nabel Gary J. Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
PAPA JOSEPH C Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Manning Paul B Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Gaeta Renee Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Nguyen Diem Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
Radhakrishnan Maha Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 32K | — | 2026-06-23 | 2026-06-24 |
SEC filings
EDGAR filings in CADL · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.